PSMA converts polyglutamated folates produced by dying tumor cells to folate, which is then absorbed by surrounding healthy cancer cells through the proton-coupled folate transporter (PCFT), reduced folate carrier (RFC), or folate receptor (FR). This evidence concerns the gene SLC46A1 and cancer.